Skip to main content
logo
Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
1.000
0.00 (0.00%)
At close: Jul 24, 2026

Curative Biotechnology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-2.04-2.36-1.93-4.46-5-4.6
Net Income
-2.84-3.53-5.82-5.47-18.82-4.67
Earnings Per Share
-0.42-0.58-1.32-1.43-5.63-2.15
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.030.020.060.060.670.16
Total Debt
3.482.942.261.12-0.56
Net Cash (Debt)
-3.44-2.92-2.2-1.070.67-0.4
Net Cash Growth
------
Net Cash Per Share
-0.51-0.48-0.50-0.280.20-0.18

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-0.64-0.95-0.49-1.5-1.6-0.19
Capital Expenditures
-----0.01-
Free Cash Flow
-0.64-0.95-0.49-1.5-1.61-0.19
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
------